Ankur Dhingra - 25 Mar 2022 Form 4 Insider Report for CareDx, Inc. (CDNA)

Reporting relationship: Chief Financial Officer
Issuer ticker: CDNA
Reported as of: 25 Mar 2022
Net transaction value: -$47,527
SEC form: 4
Accepted by SEC: 28 Mar 2022, 19:31:42 UTC
Prior SEC filing: 04 Feb 2022
Next SEC filing: 02 Jun 2022
Source filing: View source filing
Reporting owner signature: /s/ Ankur Dhingra

Key filing fact

Ankur Dhingra filed Form 4 for CareDx, Inc. (CDNA) on 28 Mar 2022.

Key facts

This page summarizes Ankur Dhingra's Form 4 filing for CareDx, Inc. (CDNA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 28 Mar 2022, 19:31.

Change

Previous filing in this sequence was filed on 04 Feb 2022.
Current net transaction value: -$47,527.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CDNA transaction

Common Stock

Tax liability

Transaction value: $47,527
Shares: -1,254
Change %: -3.6%
Price: $37.90
Shares after: 33,146
Date: 25 Mar 2022
Ownership: Direct
Footnotes: F1

CDNA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 5,000
Date: 25 Mar 2022
Ownership: By Dhingra Family Revocable Trust

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.